Company Details
- Employees
- 50
- Founded
- -
- Address
- 20271 Goldenrod Ln, Germantown,maryland 20876,united States
- Phone
- 949-574-3860
- in****@****sis.com
- Industry
- Biotechnology
- Website
- http://www.orgenesis.com
- HQ
- Germantown, Maryland
Please complete the CAPTCHA to continue
Related company profiles:
Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings Yahoo Finance
Implementation of a quality management system for decentralized manufacturing of cell and gene therapy products - technical and regulatory considerations Frontiers
Orgenesis loses CFO, more than half of its board The Business Journals
Orgenesis’s Sharp Swings Define Its High-Risk Biotech Story Finimize
Top Companies Developing Cell Therapy Treatments For Diabetes in 2025 BioInformant
Orgenesis Acquires Control of Octomera citybiz
UC Davis and Orgenesis partner to boost access to gene and cell therapies in California University of California - Davis Health
Orgenesis announces resignation of CFO and three board members Investing.com
Orgenesis and Johns Hopkins University to build CGT Maryland Center BioProcess International
Orgenesis Completes Acquisition of Tamir Biotechnology, Inc. Assets Including Broad Spectrum Antiviral Platform GlobeNewswire
Cell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard Bauer, Joins Orgenesis Business, Octomera, to Drive Continued Expansion of POCare Facilities and Service Support Yahoo Finance
Orgenesis Inc. to be delisted from Nasdaq Investing.com
Orgenesis signs muscle-derived stem cell pact with Revatis BioProcess International
Orgenesis CEO Vered Caplan Provides Letter to Shareholders GlobeNewswire
Orgenesis subsidiary Theracell enters $1 million convertible loan agreement Investing.com
EXCLUSIVE: Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinic Yahoo Finance
Catalent to buy Orgenesis’ cell therapy CDMO biz for $315m BioProcess International
Orgenesis director Ashish Nanda resigns from board effective immediately Investing.com
Orgenesis announces director resignation Investing.com
Orgenesis Announces Anti-Viral “BioShield” Program Designed GlobeNewswire
Cell and Gene Therapy Manufacturing Views Mobile Options Genetic Engineering and Biotechnology News
Grit Biotechnology’s TIL Therapy GT201 Cleared for US Trial in Advanced Solid Tumors CGTLive®
Orgenesis agrees to take over Koligo Therapeutics Pharmaceutical Technology
Orgenesis secures $2.3 million investment and strategic partnership By Investing.com Investing.com
Orgenesis Signs Master Service and Joint Venture Agreement GlobeNewswire
Market Recap: Why Orgenesis Inc. (45O) stock gets analyst attention - Weekly Trade Analysis & Risk Managed Investment Signals Trung tâm Dự báo KTTV quốc gia
Orgenesis inks Koligo buyout to gain COVID-19 cell therapy Fierce Biotech
Orgenesis, SCTbio Partner to Expand POCare Sites in Czech Republic Contract Pharma
Vered Caplan The Medicine Maker
Treating diabetes with autologous cell therapy: an interview with Orgenesis RegMedNet
Orgenesis, Cure Therapeutics to advance point-of-care development and commercialization of cell and gene therapies SelectScience
Orgenesis acquires cell therapy specialist Koligo for $15m BioProcess International
Orgenesis (ORGS) Stock Price, News & Analysis MarketBeat
Orgenesis Announces Publication of an Independent Study GlobeNewswire
Orgenesis Tackles Cell Therapy Costs, Barriers With Decentralized Model Precision Medicine Online
Precision Medicines That Are Tailored and Off-the-Rack Genetic Engineering and Biotechnology News
Orgenesis and Johns Hopkins University to create Maryland center for cell therapy manufacturing Proactive financial news
Orgenesis Signs Master Service and JV Agreement Contract Pharma
Ezra Merkin, Hedge Fund Manager Scarred by Madoff Scandal, Buys into Orgenesis citybiz
StockNewsNow.com Publishes New SNNLive Video Interview With Orgenesis BioSpace
Germfree partners with Orgenesis to enhance CGT production By Investing.com Investing.com UK
Orgenesis Inc Stock Price Today | OTC: ORGS Live Investing.com
Debunked: Ursula von der Leyen's husband is not the director of a company owned by Pfizer The Journal
Pfizer Does Not Own Orgenesis: So Why Does This Misinformation Trend on X? pandata.org
1 +141050XXXXX
1 +190848XXXXX
Find emails, phones & company data instantly
Your AI prospecting assistant
0 records × $0.02 per record
Secure checkout
Total price
$0.50
Enter your payment details below to complete the download. We'll email you the CSV as soon as it's ready.
Processing your payment...
Please wait while we complete your transaction
Sign in required
Create a free account or sign in to continue downloading the full results.
Sign up for a free account. No credit card required. Up to 10 free credits.
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.